EXOASO-STAT6
Live / Registered — Registered (as of 26 Dec 2023)
What this means for you
Registered since 26 Dec 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97601016
- Registration number
- 7256367
- Mark type
- Stylized text
- Filed
- 21 Sept 2022
- Published for opposition
- 04 Apr 2023
- Registered
- 26 Dec 2023
- Attorney of record
- Lawrence J. Crain
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and biologic preparations for use in oncology and immuno-oncology; biological components being a component in therapeutic preparations, namely, engineered exosomes delivering antisense oligonucleotides to inhibit tumor growth and induce anti-tumor immune response; therapeutic agents for the treatment of cancer and immuno-oncological diseases; therapeutic agents for inducing anti-tumor immune response
Owner
- LONZA SALES AG, BASEL, CH
- LONZA SALES AG, BASEL, CH
- Codiak Biosciences, Inc., Cambridge, MA, US
- Codiak Biosciences, Inc., Cambridge, MA, US
Prosecution history
- 30 Sept 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 30 Sept 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 30 Sept 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 26 Dec 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 26 Dec 2023 — REGISTERED-PRINCIPAL REGISTER
- 21 Nov 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Nov 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Nov 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 17 Nov 2023 — NON-FINAL ACTION E-MAILED
- 17 Nov 2023 — SU - NON-FINAL ACTION - WRITTEN
- 16 Nov 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Oct 2023 — USE AMENDMENT FILED
- 09 Nov 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Oct 2023 — TEAS STATEMENT OF USE RECEIVED
- 14 Jul 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED